Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Accounts Payables (2023 - 2026)

Cannabis Bioscience International Holdings' Accounts Payables history spans 4 years, with the latest figure at $190467.0 for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 23.31% to $190467.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $190467.0, a 23.31% increase, with the full-year FY2025 number at $100343.0, down 39.5% from a year prior.
  • Accounts Payables hit $190467.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from $159116.0 in the prior quarter.
  • Over the last five years, Accounts Payables for CBIH hit a ceiling of $257527.0 in Q1 2024 and a floor of $100343.0 in Q2 2025.
  • Historically, Accounts Payables has averaged $159665.0 across 4 years, with a median of $159116.0 in 2025.
  • Biggest five-year swings in Accounts Payables: surged 49.02% in 2024 and later plummeted 40.02% in 2025.
  • Tracing CBIH's Accounts Payables over 4 years: stood at $213521.0 in 2023, then fell by 22.2% to $166119.0 in 2024, then fell by 4.22% to $159116.0 in 2025, then grew by 19.7% to $190467.0 in 2026.
  • Business Quant data shows Accounts Payables for CBIH at $190467.0 in Q1 2026, $159116.0 in Q4 2025, and $101297.0 in Q3 2025.